Clot stiffness.fibrinogen contribution.tissue factor induced platelet glycoprotein IIb-IIIa receptor inhibited post heparin neutralization:Pres:Pt:Bld:Qn:US

Preferred Label : Clot stiffness.fibrinogen contribution.tissue factor induced platelet glycoprotein IIb-IIIa receptor inhibited post heparin neutralization:Pres:Pt:Bld:Qn:US;

LOINC status : ACTIVE;

LOINC display name : Clot stiffness.fibrinogen contribution.tissue factor induced platelet glycoprotein IIb-IIIa receptor inhibited post heparin neutralization US (Bld) [Pressure];

LOINC long common name : Clot stiffness.fibrinogen contribution.tissue factor induced platelet glycoprotein IIb-IIIa receptor inhibited (elasticity) in Blood by US --post heparin neutralization;

LOINC short name : Clot stiff TF ind IIb-IIIa inh p hep neu;

LOINC description : Contribution of fibrinogen to clot stiffness, where clot formation is induced by tissue factor via the extrinsic coagulation pathway and platelet contribution is blocked, as are the effects of any heparin in the sample.;

Détails

Origin ID

96707-5;

UMLS CUI

C5425728;

Has challenge
- post heparin neutralization [LOINC Challenge]
Has component
- Clot [LOINC component]
- Clot stiffness [LOINC component]
- Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [LOINC component]
- Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited^post heparin neutralization [LOINC component]
- Fibrinogen [LOINC component]
- Heparin [LOINC component]
- Heparin neutralization [LOINC component]
- Platelet [LOINC component]
- Platelet glycoprotein [LOINC component]
- Platelet glycoprotein IIb/IIIa [LOINC component]
- post [LOINC component]
Has method
- Ultrasound [LOINC method]
Has property
- Pressure [LOINC Property]
Has system
- Blood [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients